Business & Markets
Weston family agrees to buy Boots in $8.9 billion deal
The agreement would give the Weston family’s Canadian holding company operational control, with Fairfax expected to own half the equity after closing. Regulatory and other conditions remain.
Executive summary
- The agreement covers Boots’ core UK and Ireland business: Wittington Investments, the Weston family’s Canadian holding company, and Fairfax Financial agreed to acquire Boots’ retail operations in the UK and Ireland, Boots Opticians, No7 Beauty, and its Thailand and franchised businesses for about $8.9 billion, including assumed debt.[1][2][3]
- The transaction has not closed: Fairfax expects to own 50% of Boots’ equity after closing, while Wittington would retain operational control. The companies expect the transaction to close in the first quarter of 2027, subject to customary conditions.[1][3]
- Some businesses are excluded: The agreement does not include The Boots Group’s interests in Farmacias Benavides in Mexico or Alliance Healthcare Deutschland; the current owner will retain them.[1][3]
Wittington Investments and Fairfax Financial Holdings said they had entered agreements to acquire Boots’ retail operations in the United Kingdom and Ireland, its opticians business, the No7 Beauty Company, and its Thailand and franchised businesses. The announced purchase price is about $8.9 billion, inclusive of assumed debt. Reuters reported that the sellers are Sycamore Partners and the Pessina family.[1][2][3]
Boots operates about 1,800 stores and employs roughly 50,000 people, according to the Guardian. It combines pharmacy services with beauty, personal care and optician services, making the change in ownership relevant to both British retail and community healthcare. The transaction is an agreement; the buyers have not taken control yet.[3][4]
Fairfax says it has committed to provide or arrange up to about $2.3 billion toward the purchase price. It expects to own 50% of Boots’ equity once the transaction closes, while Wittington would have operational control and Weston family executive Galen Weston would serve as chair. The structure gives Wittington control without making it the sole equity owner.[1][2]
Wittington has said it sees an opportunity to invest further in Boots and renew its operating focus. Those are the buyer’s stated intentions, not disclosed spending targets or guarantees about future store numbers, jobs or healthcare services. The announcement does not provide a detailed investment schedule.[1][2]
The transaction is subject to customary closing conditions and is expected to be completed in the first quarter of 2027. Until those conditions are met, the existing owners remain responsible for the businesses covered by the agreement. The announcement does not identify a specific regulatory decision date.[1][3]
The sale excludes the current owner’s interests in Farmacias Benavides, a Mexican pharmacy chain, and Alliance Healthcare Deutschland, a German pharmaceutical distributor. The carve-outs mean the $8.9 billion transaction is for the named Boots operations and brands, not every business associated with the wider group.[1][3]